Medicare limits coverage of $28,000-a-year Alzheimer’s drug
By RICARDO ALONSO-ZALDIVAR Associated Press WASHINGTON (AP) — Medicare says it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned. Tuesday’s decision from the Centers for Medicare and Medicaid Services is a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but
Continue Reading